NAD+ 500 mg
This lot was tested by Janoshik. Purity was measured by RP-HPLC, 220 nm. The signed report is reproduced below; the figures on this page are transcribed from it.
- Batch number
- BK-NAD-500
- Compound
- NAD+ 500 mg
- Laboratory
- Janoshik
- Purity
- 99.41 % (RP-HPLC, 220 nm)
- Purity, RP-HPLC, 220 nm
- 99.41 %
- Laboratory
- Janoshik
What this certificate shows
Purity 99.41 %. Reversed-phase HPLC separates the contents of the vial by how they interact with the column, and a UV detector measures each peak. 99.41 % of the detected material in lot BK-NAD-500 is the target peptide, NAD+ 500 mg; the remaining 0.59 % is made up of closely related sequences and synthesis by-products. Purity describes what the peptide portion is, not how much powder is in the vial.
How each figure is measured, and the limits a lot must meet before release, are set out in our testing methods. For in-vitro laboratory research only.